Skip to main content
Erschienen in: Abdominal Radiology 3/2005

01.06.2005

Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts

verfasst von: R. Shimoda, K. Horiuchi, S. Hagiwara, H. Suzuki, Y. Yamazaki, T. Kosone, T. Ichikawa, H. Arai, T. Yamada, T. Abe, H. Takagi, M. Mori

Erschienen in: Abdominal Radiology | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

The type, incidence, and severity of complications of balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices should be precisely estimated. Complications were evaluated in 38 patients who had fundic gastric varices and 43 B-RTO procedures during injection of ethanolamine oleate (phase 1), within 4 h after injection (phase 2), 24 h after injection (phase 3), and from 24 h to 10 days after injection (phase 4). Endoscopic evaluation at 8 weeks showed resolution of gastric varices in 35 of 38 patients (92%) and smaller varices in the remaining three (8%). B-RTO caused transient hypertension in 35% of patients, hemoglobinuria in 49%, and fever in 33% during phases 1, 2, and 3, respectively. Pleural effusion, pulmonary infarction, ascites, gastric ulcers with unique appearance, localized mosaic-like change of gastric mucosa, and hemorrhagic portal hypertensive gastropathy were noted in phase 4. There were no fatalities. Lactate dehydrogenase, aspartate aminotransferase, and bilirubin increased on day 1. Each datum was retrieved within 7 days. The severity of lactate dehydrogenase elevation correlated significantly with the volume of infused ethanolamine oleate. Thus, B-RTO is a safe and effective management of fundic varices. However, short-term hemodynamic change after B-RTO may cause gastric mucosal damage. Pulmonary infarction and pleural effusion are potential complications.
Literatur
1.
Zurück zum Zitat Sarin, SK, Lahoti, D, Saxena, SP, et al. 1992Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patientsHepatology1613431349PubMed Sarin, SK, Lahoti, D, Saxena, SP,  et al. 1992Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patientsHepatology1613431349PubMed
2.
Zurück zum Zitat Akiyoshi, N, Shijo, H, Iida, T, et al. 2000The natural history and prognostic factors in patients with cirrhosis and gastric fundic varices without prior bleedingHepatol Res17145155CrossRefPubMed Akiyoshi, N, Shijo, H, Iida, T,  et al. 2000The natural history and prognostic factors in patients with cirrhosis and gastric fundic varices without prior bleedingHepatol Res17145155CrossRefPubMed
3.
Zurück zum Zitat Kanagawa, H, Mima, S, Kouyama, H, et al. 1996Treatment of gastric fundic varices by balloon-occluded retrograde transvenous obliterationJ Gastroenterol Hepatol115158PubMed Kanagawa, H, Mima, S, Kouyama, H,  et al. 1996Treatment of gastric fundic varices by balloon-occluded retrograde transvenous obliterationJ Gastroenterol Hepatol115158PubMed
4.
Zurück zum Zitat Shiha, G, El-Sayed, SS 1999Gastric variceal ligation: a new techniqueGastrointest Endosc49437441PubMed Shiha, G, El-Sayed, SS 1999Gastric variceal ligation: a new techniqueGastrointest Endosc49437441PubMed
5.
Zurück zum Zitat Barange, K, Peron, JM, Imani, K, et al. 1999Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varicesHepatology3011391143CrossRefPubMed Barange, K, Peron, JM, Imani, K,  et al. 1999Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varicesHepatology3011391143CrossRefPubMed
6.
Zurück zum Zitat Kakio, T, Ito, T, Sue, K, et al. 1993Hemostasis of gastric variceal hemorrhage by transileocoecal and transhepatic obliterationActa Med Okayama473943PubMed Kakio, T, Ito, T, Sue, K,  et al. 1993Hemostasis of gastric variceal hemorrhage by transileocoecal and transhepatic obliterationActa Med Okayama473943PubMed
7.
Zurück zum Zitat Huang, YH, Yeh, HZ, Chen, GH, et al. 2000Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histocryl) injection: long-term efficacy and safetyGastrointest Endosc52160167CrossRefPubMed Huang, YH, Yeh, HZ, Chen, GH,  et al. 2000Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histocryl) injection: long-term efficacy and safetyGastrointest Endosc52160167CrossRefPubMed
8.
Zurück zum Zitat Sarin, SK 1997Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experienceGastrointest Endosc46814PubMed Sarin, SK 1997Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experienceGastrointest Endosc46814PubMed
9.
Zurück zum Zitat Chikamori, F, Shibuya, S, Takase, Y, et al. 1996Transjugular retrograde obliteration for gastric varicesAbdom Imaging21299303CrossRefPubMed Chikamori, F, Shibuya, S, Takase, Y,  et al. 1996Transjugular retrograde obliteration for gastric varicesAbdom Imaging21299303CrossRefPubMed
10.
Zurück zum Zitat Sonomura, T, Sato, M, Kishi, K, et al. 1998Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility studyCardiovasc Intervent Radiol212730CrossRefPubMed Sonomura, T, Sato, M, Kishi, K,  et al. 1998Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility studyCardiovasc Intervent Radiol212730CrossRefPubMed
11.
Zurück zum Zitat Hirota, S, Matsumoto, S, Tomita, M, et al. 1999Retrograde transvenous obliteration of gastric varicesRadiology211349356PubMed Hirota, S, Matsumoto, S, Tomita, M,  et al. 1999Retrograde transvenous obliteration of gastric varicesRadiology211349356PubMed
12.
Zurück zum Zitat Koito, K, Namieno, T, Nagakawa, T, et al. 1996Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collateralsAJR16713171320PubMed Koito, K, Namieno, T, Nagakawa, T,  et al. 1996Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collateralsAJR16713171320PubMed
13.
Zurück zum Zitat Chikamori, F, Kuniyoshi, N, Shibuya, S 2000Transjugular retrograde obliteration for chronic portosystemic encephalopathyAbdom Imaging25567571CrossRefPubMed Chikamori, F, Kuniyoshi, N, Shibuya, S 2000Transjugular retrograde obliteration for chronic portosystemic encephalopathyAbdom Imaging25567571CrossRefPubMed
14.
Zurück zum Zitat Akahane, T, Iwasaki, T, Kobayashi, N, et al. 1997Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliterationAm J Gastroenterol9210261030PubMed Akahane, T, Iwasaki, T, Kobayashi, N,  et al. 1997Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliterationAm J Gastroenterol9210261030PubMed
15.
Zurück zum Zitat Chikamori, F, Kuniyoshi, N, Shibuya, S, et al. 2000Short-term hemodynamic effects of transjugular retrograde obliteration of gastric varices with gastrorenal shuntDig Surg7332336CrossRef Chikamori, F, Kuniyoshi, N, Shibuya, S,  et al. 2000Short-term hemodynamic effects of transjugular retrograde obliteration of gastric varices with gastrorenal shuntDig Surg7332336CrossRef
16.
Zurück zum Zitat Matsumoto, A, Hamamoto, N, Nomura, T, et al. 1999Balloon-occluded retrograde transvenous obliteration of high risk gastric fundic varicesAm J Gastroenterol94643649CrossRefPubMed Matsumoto, A, Hamamoto, N, Nomura, T,  et al. 1999Balloon-occluded retrograde transvenous obliteration of high risk gastric fundic varicesAm J Gastroenterol94643649CrossRefPubMed
17.
Zurück zum Zitat Wada, H, Hashizume, M, Yamaga, H, et al. 1990Hemodynamic and morphological changes in the dog kidney after injection of 5% ethanolamine oleate into the superior vena cavaEur Surg Res226370PubMed Wada, H, Hashizume, M, Yamaga, H,  et al. 1990Hemodynamic and morphological changes in the dog kidney after injection of 5% ethanolamine oleate into the superior vena cavaEur Surg Res226370PubMed
18.
Zurück zum Zitat Palejwala, AA, Smart, HL, Hughes, M 2000Multiple pulmonary glue emboli following gastric variceal obliterationEndoscopy32S1S2CrossRefPubMed Palejwala, AA, Smart, HL, Hughes, M 2000Multiple pulmonary glue emboli following gastric variceal obliterationEndoscopy32S1S2CrossRefPubMed
19.
Zurück zum Zitat Vallgren, S, Sigurdsson, GH, Moberger, G, et al. 1988Influence of intravenous injection of sclerosing agents on the respiratory functionActa Chir Scand154271276PubMed Vallgren, S, Sigurdsson, GH, Moberger, G,  et al. 1988Influence of intravenous injection of sclerosing agents on the respiratory functionActa Chir Scand154271276PubMed
20.
Zurück zum Zitat Kotzampassi, K, Eleftheriadis, E, Aletras, H 1990The ‘mosaic-like’ pattern of portal hypertensive gastric mucosa after variceal eradication by sclerotherapyJ Gastroenterol Hepatol5659663PubMed Kotzampassi, K, Eleftheriadis, E, Aletras, H 1990The ‘mosaic-like’ pattern of portal hypertensive gastric mucosa after variceal eradication by sclerotherapyJ Gastroenterol Hepatol5659663PubMed
21.
Zurück zum Zitat Sarin, SK, Shahi, HM, Jain, M, et al. 2000The natural history of portal hypertensive gastropathy: influence of variceal eradicationAm J Gastroenterol9528882893CrossRefPubMed Sarin, SK, Shahi, HM, Jain, M,  et al. 2000The natural history of portal hypertensive gastropathy: influence of variceal eradicationAm J Gastroenterol9528882893CrossRefPubMed
22.
Zurück zum Zitat Boldys, H, Romanczyk, T, Hartleb, M, et al. 1996Short-term effects of variceal sclerotherapy on portal hypertensive gastropathyEndoscopy28735739PubMed Boldys, H, Romanczyk, T, Hartleb, M,  et al. 1996Short-term effects of variceal sclerotherapy on portal hypertensive gastropathyEndoscopy28735739PubMed
23.
Zurück zum Zitat Iwao, T, Toyonaga, A, Oho, K, et al. 1997Portal-hypertensive gastropathy develops less in patients with cirrhosis and fundic varicesJ Hepatol2612351241CrossRefPubMed Iwao, T, Toyonaga, A, Oho, K,  et al. 1997Portal-hypertensive gastropathy develops less in patients with cirrhosis and fundic varicesJ Hepatol2612351241CrossRefPubMed
24.
Zurück zum Zitat Fukuda, T, Hirota, S, Matsumoto, S, et al. 2004Application of balloon-occluded retrograde transvenous obliteration to gastric varices complicating refractory ascitesCardiovasc Intervent Radiol276467PubMed Fukuda, T, Hirota, S, Matsumoto, S,  et al. 2004Application of balloon-occluded retrograde transvenous obliteration to gastric varices complicating refractory ascitesCardiovasc Intervent Radiol276467PubMed
25.
Zurück zum Zitat Martin, PY, Schrier, RW 1997Pathogenesis of water and sodium retention in cirrhosisKidney Int59S43S49 Martin, PY, Schrier, RW 1997Pathogenesis of water and sodium retention in cirrhosisKidney Int59S43S49
Metadaten
Titel
Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts
verfasst von
R. Shimoda
K. Horiuchi
S. Hagiwara
H. Suzuki
Y. Yamazaki
T. Kosone
T. Ichikawa
H. Arai
T. Yamada
T. Abe
H. Takagi
M. Mori
Publikationsdatum
01.06.2005
Erschienen in
Abdominal Radiology / Ausgabe 3/2005
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-004-0270-8

Weitere Artikel der Ausgabe 3/2005

Abdominal Radiology 3/2005 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.